Tag: Therapeutics
Share Skyrockets on news of positive early-stage results from GEN-009 Clinical...
Genocea Biosciences, Inc. (NASDAQ: GNCA) skyrocketed today based on news of promising data from its early stage clinical trials of GEN-009, its neoantigen vaccine candidate....
New Drugs show promise in curbing the Gonorrhea Menace
Gonorrhoea, caused by a bacterial pathogen N. gonorrhoea, is the second most commonly reported sexually transmitted disease in the U.S alone. The data made available...
New Age Therapeutics Offer Hope to Patients of Multiple Sclerosis
Multiple Sclerosis (MS) is one of the diseases that will be covered under the National Neurological Conditions Surveillance System (NNCSS), a system that is being built by the Centers...
5 Promising Companies In The Non-Opioid Drug Industry
Chronic Pain is the leading cause for seeking medical aid in the U.S. A study undertaken by the Centres for disease control and prevention...
We are looking for talented interns to learn and help investors find valuable companies.